Celia Patricia Hart

Title: Celia Patricia Hart: Innovator in Neuropathic Pain Treatment

Introduction

Celia Patricia Hart is a distinguished inventor based in Cambridge, GB. She has made significant contributions to the field of medical science, particularly in the treatment of neuropathic pain. With a total of 2 patents, her work focuses on innovative methods that utilize specific binding members for Nerve Growth Factor (NGF).

Latest Patents

Celia's latest patents include groundbreaking methods for treating neuropathic pain using anti-NGF antibody molecules. These specific binding members are designed to neutralize NGF activity, which is crucial in various disorders. Her patents detail methods for using these anti-NGF antibody molecules in the diagnosis and treatment of NGF-related disorders, including pain, asthma, chronic obstructive pulmonary disease, pulmonary fibrosis, diabetic neuropathy, cardiac arrhythmias, HIV, arthritis, psoriasis, and cancer.

Career Highlights

Throughout her career, Celia has worked with notable companies such as Medimmune Limited and Elan Pharma International Limited. Her experience in these organizations has allowed her to develop and refine her innovative approaches to medical treatment.

Collaborations

Celia has collaborated with esteemed colleagues, including Ruth Franks and Andrew Grier Buchanan. These partnerships have contributed to her success and the advancement of her research.

Conclusion

Celia Patricia Hart is a remarkable inventor whose work in neuropathic pain treatment has the potential to impact many lives. Her innovative patents and collaborations highlight her dedication to advancing medical science.